⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1310229 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL9456636 | 0.97 | — | — | |
| SCHEMBL5264575 | 0.84 | RAB9A (0.39) | — | |
| Trifluoroacetic Acid SCHEMBL29678801 | 0.82 | RAB9A (0.33) | — | |
| SCHEMBL2895036 | 0.80 | — | — | |
| SCHEMBL3360045 | 0.79 | ALDH1A1 (0.41) | — | |
| Propane SCHEMBL10822346 | 0.78 | RAB9A (0.35) | — | |
| SCHEMBL3890266 | 0.76 | — | — | |
| SCHEMBL9229583 | 0.76 | RAB9A (0.37) | — | |
| SCHEMBL1583473 | 0.74 | ALDH1A1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 980 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240158337-A1 | GAS-PHASE OXIDATIVE COUPLING OF ALCOHOLS AND AMINES USING HETEROGENEOUS CATALYSTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA | 2024-05-16 | — | — | US | claimed |
| EP-4211468-A2 | EX VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT | Glympse Bio, Inc. (US) | 2023-07-19 | — | — | EP | claimed |
| CN-116438456-A | Detection of in vitro protease activity for disease detection/diagnosis, staging, monitoring and treatment | 格里姆普斯生物股份有限公司 | 2023-07-14 | — | — | CN | claimed |
| WO-2023283933-A1 | COMPOUNDS USEFUL AS KRAS G12D INHIBITORS | SILEXON BIOTECH CO., LTD. (CN) | 2023-01-19 | — | — | WO | claimed |
| WO-2023284730-A1 | ALKYLIDENE DERIVATIVES AS KRAS INHIBITORS | NIKANG THERAPEUTICS, INC. (US) | 2023-01-19 | — | — | WO | claimed |
| WO-2023284881-A1 | HETEROCYCLIC COMPOUNDS USEFUL AS KRAS G12D INHIBITORS | SILEXON AI TECHNOLOGY CO., LTD. (CN) | 2023-01-19 | — | — | WO | claimed |
| CN-110951310-B | Use of carbamates as organic solvents | 万华化学（北京）有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-110951310-A | Use of carbamates as organic solvents | 万华化学（北京）有限公司 | 2020-04-03 | — | — | CN | claimed |
| CN-110709396-A | Novel compound inhibitors of the YAP/TAZ-TEAD interaction and their use in the treatment of malignant mesothelioma | 伊文蒂瓦公司 | 2020-01-17 | — | — | CN | claimed |
| CN-104134820-B | Electrolyte comprising eutectic mixture and secondary battery comprising the same | 株式会社LG化学 | 2016-08-31 | — | — | CN | claimed |
| EP-0055562-B1 | CEPHALOSPORIN DERIVATIVES | ICI PHARMA (FR) | 1986-02-12 | — | — | EP | claimed |
| EP-0158922-A2 | Tetrahydrofuran-2-ylmethylamines | BAYER AG (DE) | 1985-10-23 | — | — | EP | claimed |
| EP-0131793-A2 | 5-Aminomethyl-1,3-oxathiolanes | BAYER AG (DE) | 1985-01-23 | — | — | EP | claimed |
| EP-0055099-B1 | PENICILLIN DERIVATIVES | ICI PHARMA (FR) | 1984-10-24 | — | — | EP | claimed |
| EP-0075434-A2 | Cephalosporins, their preparation and their pharmaceutical compositions | ICI PHARMA (FR) | 1983-03-30 | — | — | EP | claimed |
| EP-0072608-A2 | Process for the preparation of cephalosporin derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-02-23 | — | — | EP | claimed |
| EP-0071370-A2 | Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them | ICI PHARMA (FR) | 1983-02-09 | — | — | EP | claimed |
| EP-0055562-A2 | Cephalosporin derivatives | ICI PHARMA (FR) | 1982-07-07 | — | — | EP | claimed |
| EP-0055099-A1 | Penicillin derivatives | ICI PHARMA (FR) | 1982-06-30 | — | — | EP | claimed |
| US-3953302-A | Prevention of dendritic plating of lithium | P. R. MALLORY & CO. INC. (US) | 1976-04-27 | — | — | US | claimed |